Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
to serve as a technical expert for the PeopleSoft Human Capital Management (HCM) application. This position analyzes customer needs and develops customizations, reports, interfaces and bolt-on solutions
-
to enable corrective action to be initiated. Provides information, service, and assistance to the public and/or students, staff and faculty. Communicates and interfaces with university police or other
-
brain-computer interfaces by integrating neuroengineering, visual neuroscience, and systems electrophysiology. The Research Specialist will work closely the faculty and staff to conduct daily experiments
-
) Established Researcher (R3) Application Deadline 29 Apr 2026 - 22:00 (UTC) Country France Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not
-
(CRUK) research programme. This role offers an exciting opportunity to contribute to cutting-edge work at the interface of neuro-oncology, nanomedicine, and translational cancer research, within a
-
the lab of Dr. Zachary Knight at the University of California, San Francisco. The Knight lab studies how eating and drinking are regulated by the brain and by signals from the gastrointestinal tract. We
-
Description (Personnel Program): PSS Salary Grade: 19 Pay Rate/Range: The budgeted salary range that the University reasonably expects to pay for this position is $28.27 to $35.77/hr. Salary offers
-
Resource Center, Affinity Groups and an Employee Assistance Program. • Optional lifestyle benefits such as pet, accident, and critical illness insurance, giving you peace of mind and the support you need
-
Sorbonne Université SIS (Sciences, Ingénierie, Santé) | Paris 15, le de France | France | 28 days ago
for the transitions between different conformational states of biomolecules, forming complexes among them or with small ligands like drugs. The project is at the interface between physics, computational science and
-
an exciting opportunity to work at the interface of neuro-oncology, nanomedicine, and translational cancer research, contributing to a programme with clear clinical relevance and long-term vision